Charles Schwab Investment Management Inc Ab Cellera Biologics Inc. Transaction History

Charles Schwab Investment Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$7.31 - $11.18 $46,506 - $71,127	6,362 Added 1.37%	472,389 $3.56 Million
Q4 2022 Feb 13, 2023	BUY	$9.48 - $14.52 $86,078 - $131,841	9,080 Added 1.99%	466,027 $4.72 Million
Q3 2022 Nov 14, 2022	SELL	$9.2 - $13.68 $3,155 - $4,692	-343 Reduced 0.08%	456,947 $4.52 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $2.62 Million - $4.87 Million	457,290 New	457,290 $4.87 Million

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.